Cargando…
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial
BACKGROUND: Neutropenic sepsis remains a common treatment complication for patients receiving systemic anti-cancer treatment. The UK National Institute for Health and Care Excellence have not recommended switching from empirical intravenous antibiotics to oral antibiotics within 48 h for patients as...
Autores principales: | Forde, Caroline, McMullan, Ronan, Clarke, Mike, Wilson, Richard H., Plummer, Ruth, Grayson, Margaret, McDowell, Cliona, Agus, Ashley, Doran, Annmarie, McAuley, Danny F., Thomas, Anne L., Barnes, Rosemary A., Adams, Richard, Chau, Ian, Coyle, Vicky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251886/ https://www.ncbi.nlm.nih.gov/pubmed/32460818 http://dx.doi.org/10.1186/s13063-020-04241-1 |
Ejemplares similares
-
Acute hypoxaemic respiratory failure after treatment with lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal: long-term outcomes from the REST randomised trial
por: Boyle, Andrew J, et al.
Publicado: (2023) -
Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study protocol for a randomized controlled trial
por: Casarin, Annalisa, et al.
Publicado: (2015) -
Effectiveness of a programme of exercise on physical function in survivors of critical illness following discharge from the ICU: study protocol for a randomised controlled trial (REVIVE)
por: O'Neill, Brenda, et al.
Publicado: (2014) -
Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol
por: Cross, Laurence JM, et al.
Publicado: (2013) -
Erratum to: Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol
por: Cross, Laurence J. M., et al.
Publicado: (2017)